Merck & Co Inc (MRK.N) Analysts | Reuters.com
Edition:
United States

Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

57.05USD
4:00pm EDT
Change (% chg)

$1.47 (+2.64%)
Prev Close
$55.58
Open
$56.25
Day's High
$57.14
Day's Low
$55.98
Volume
3,325,781
Avg. Vol
2,831,617
52-wk High
$60.06
52-wk Low
$45.70

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.91 December 29 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 6 6 6 5
(3) HOLD 13 13 13 13
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.45 2.45 2.45 2.48

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 13 9,789.70 10,016.00 9,613.21 10,217.00
Quarter Ending Sep-16 13 10,069.50 10,381.00 9,814.00 10,589.00
Year Ending Dec-16 16 39,518.00 40,600.00 38,981.80 40,971.60
Year Ending Dec-17 20 39,089.00 40,570.00 37,190.00 41,392.40
Earnings (per share)
Quarter Ending Jun-16 16 0.91 0.94 0.89 0.88
Quarter Ending Sep-16 16 0.98 1.02 0.94 1.05
Year Ending Dec-16 19 3.72 3.77 3.65 3.82
Year Ending Dec-17 22 3.76 4.00 3.34 3.98
LT Growth Rate (%) 6 3.35 6.75 -0.70 4.07

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 9,463.70 9,312.00 151.70 1.60
Quarter Ending Dec-15 10,351.90 10,215.00 136.94 1.32
Quarter Ending Sep-15 10,079.80 10,073.00 6.82 0.07
Quarter Ending Jun-15 9,800.44 9,785.00 15.44 0.16
Quarter Ending Mar-15 9,068.35 9,425.00 356.65 3.93
Earnings (per share)
Quarter Ending Mar-16 0.85 0.89 0.04 4.22
Quarter Ending Dec-15 0.91 0.93 0.02 2.09
Quarter Ending Sep-15 0.91 0.96 0.05 4.95
Quarter Ending Jun-15 0.81 0.86 0.05 6.04
Quarter Ending Mar-15 0.75 0.85 0.10 13.99

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 9,789.70 9,789.70 9,771.62 9,800.11 10,217.00
Quarter Ending Sep-16 10,069.50 10,069.50 10,057.20 10,105.00 10,589.00
Year Ending Dec-16 39,518.00 39,518.00 39,485.50 39,859.30 40,971.60
Year Ending Dec-17 39,089.00 39,089.00 39,089.70 39,693.10 41,392.40
Earnings (per share)
Quarter Ending Jun-16 0.91 0.91 0.91 0.91 0.88
Quarter Ending Sep-16 0.98 0.98 0.98 0.98 1.05
Year Ending Dec-16 3.72 3.72 3.71 3.71 3.82
Year Ending Dec-17 3.76 3.76 3.75 3.78 3.98

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 0 1 0
Quarter Ending Sep-16 0 0 1 0
Year Ending Dec-16 0 0 1 0
Year Ending Dec-17 0 0 0 1
Earnings
Quarter Ending Jun-16 0 0 1 0
Quarter Ending Sep-16 0 0 1 0
Year Ending Dec-16 0 0 1 0
Year Ending Dec-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.